Clinical trials
Recruiting Phase 1/2 Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 10 |
| 2023 | 13 |
| 2024 | 22 |
| 2025 | 17 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 89 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Biotech | 8 |
| AstraZeneca | 3 |
| Chinese PLA General Hospital | 3 |
| Princess Maxima Center for Pediatric Oncology | 3 |
| Regeneron Pharmaceuticals | 3 |
| Cellectis S.A. | 2 |
| Genfleet Therapeutics (Shanghai) Inc. | 2 |
| ModernaTX, Inc. | 2 |
| National Cancer Institute (NCI) | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 89 |
| Neoplasms | 13 |
| Multiple Myeloma | 12 |
| Lymphoma, B-Cell | 8 |
| Lymphoma | 7 |
| Burkitt Lymphoma | 6 |
| Glioblastoma | 6 |
| Neoplasm Metastasis | 6 |
| Ovarian Neoplasms | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
Trials
Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.